You're reading the free version. Trader adds the live tape and alerts.
Start tracking
FTH Conversion Disclosure
Hahn Stephen M. · SEC Form 4 · Filed Jun 16, 2026
Conversion
Reported value range
Not reported
Hahn Stephen M. Director
FTH
Transaction date
Jun 15, 2026
Public filing date
Jun 16, 2026
Filing lag
Filed 1 day later
FTH daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Preferred Stock on Common Stock
- Quantity / price
- 44.76 shares
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0002137706-26-000003
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Sensei Biotherapeutics, Inc. FTH | Conversion | Jun 15, 2026 | Not reported |
| Sensei Biotherapeutics, Inc. FTH Current | Conversion | Jun 15, 2026 | Not reported |
| Sensei Biotherapeutics, Inc. FTH | Award | Jun 12, 2026 | $0 |